Summary For 50 years, serotonin has been in the centre of the search for the mechanisms and control of sleep. Serotonergic neurotransmission is related to the behavioural state of the animal and plays an important role in modulation of the behavioural state, by interacting with other brain areas modulating circadian rhythm, sleep and waking. Serotonergic activity may be accompanied by waking or sleep depending on the brain area and receptor type involved in the response, on the current behavioural state and on the concomitant agonism/antagonism of other neurotransmitter systems.  2002 Published by Elsevier Science Ltd research have shown that sleep is a complex pro-
INTRODUCTION
cess, and the idea that it is governed by a single brain structure or by a single neurophysiologically The neurotransmitter serotonin has played a crucial or neurobiochemically activated mechanism is no role in the last 50 years of search for the mechanisms longer feasible. and control of sleep. Indeed, for a short period in
In this paper will be reviewed some of the data the 1960s serotonin was by many considered the indicating the versatile role of serotonin in sleep neurotransmitter of sleep, until it turned around, and waking, including some of the old work which for a while a full 180°, with the recording of raphe the hypothesis on the sleep-inducing effect of seroneurones in naturally sleeping animals, to serotonin tonin was based on. Much of the early data seem being a waking neurotransmitter. The truth probably to have been forgotten in light of the more recent lies somewhere in between or, rather, both may be data on raphe nucleus activity and serotonin release true. From the earliest studies of serotonin and in the different sleep and waking stages, which sleep, both types of responses, and often biphasic emphasize the role of serotonin as a modulator of responses (arousal followed by synchrony and waking activities. The early experiments were often sleep), have been recorded following serotonergic done with crude methods and "dirty" drugs, which manipulations. As a neurotransmitter, acting on for each experiment seen in isolation might explain many different receptors, serotonin may be involved why the results were obtained. However, together in many processes relevant for the control of both they tell a story which is not to be ignored. sleep and waking, depending on the localization in Since the description of the cellular activity of the brain, the type of receptor it acts on and the the raphe neurones was such a milestone in serocurrent state of the individual. The last decades of tonin-sleep research, this review is in two parts, the early data and the last 25 years of researchwith a few exceptions -being grouped separately.
R. URSIN 58 the last part of the paper some of these findings ventricle via an implanted cannula induced a typical sleep picture with exaggerated high voltage slow are briefly reviewed, with particular reference to the relations to serotonergic activity.
waves within 1-5 min [6] . Thus, in Koella's work, the arousal response seems to be a thalamic pheSeveral recent reviews emphasize specific aspects of the serotonin, sleep and waking story and should nomenon, while the synchronization-sleep effect was proposed to stem from stuctures in the floor be consulted for more detailed information [1] [2] [3] [4] .
of the fourth ventricle: area postrema and the nucleus tractus solitarius. Nucleus tractus solitarius is a site for integration of visceral information and
THE EARLY DATA
its modulation by afferent neural systems, among others afferents from the raphe nuclei, serotonin
Administration of serotonin into the mainly having a depressant action possibly via 5-brain HT 1B receptors [8] . It is also rich in opioid receptors, After serotonin had been found in the central the stimulation of which produces a hypnotic effect nervous system [5] , an effect on synchronization by enhancing slow wave sleep (SWS) [9] . and/or sleep was described by several researchers. The biphasic effects of serotonin administration were noted in some of the very first studies on
Lesions of the raphe nuclei serotonin and sleep. Bradley (cited by Koella [6])
The description of serotonergic cells in the raphe injected low doses of 5-hydroxytryptamine (5-HT) nuclei of the brain stem and their projection [10, into the lateral ventricle in cats. After an initial 11] made it possible to lesion serotonergic neurones period of arousal, signs of drowsiness and sleep selectively. The rostral group, the dorsal and medial occurred. Similar effects was observed following raphe nuclei, projecting to the forebrain (thalamus, intravenous injection: initial arousal followed by hypothalamus, striatum, hippocampus, and frontal prolonged hypersynchrony was observed following cortex) was of main interest in this context. administration of low doses (5-30 g/kg) in curJouvet and coworkers (see reviews by Jouvet arized, unanaesthetized cats. In "cerveau isolé" cats [12, 13]) performed subtotal lesions of the raphe (cats with a brain stem transection at the level of nuclei in cats and found a reduction of sleep parthe mesencephalic colliculi), injection of serotonin allelled by a reduction of brain serotonin. Together lead to immediate arousal, with subsequent signs with the para-chlorophenylalanine (pCPA) data this of electroencephalogram (EEG) synchrony [7] .
was the main evidence for the serotonin-sleep Koella and coworkers did several studies aimed hypothesis, postulating the ascending serotonergic at establishing the effects of serotonin on sleep and system as essential for SWS [12] . In rats, however, at clarifying the site and mechanisms of action. They raphe lesions tended to induce hyperactivity but studied recruiting responses, which are thalamic not loss of sleep [14] . Also, it appeared that a synchronization responses produced by medial thaltemporary raphe lesion by cooling induced sleep amic slow frequency (10/s) stimulation. Small doses when it was performed during waking and induced of serotonin administered into the carotid artery waking when it was performed during sleep, the led to an initial attenuation or complete suppression opposite of what would be expected [15] of the recruiting responses. This was followed by a prolonged period of increased recruiting lasting for up to 20 min. Similar biphasic effects were seen Blocking serotonin formation by parain the EEG, i.e. arousal followed by hypersynchrony, chlorophenylalanine and the effects were accompanied by an increase followed by a decrease in pupillary size, suggestive pCPA is a compound which blocks tryptophan of arousal followed by true sleep. Following a brain hydroxylase, the enzyme catalysing the transstem transection at the pretrigeminal level, only formation of serotonin from its precursor, the arousal signs were seen [7] . In lightly anaesthetized amino acid l-tryptophan. Several studies have demcats, injection of serotonin into the third and fourth onstrated that sleep is blocked or heavily reduced ventricles induced EEG and ocular signs of sleep. In in a period following administration of pCPA, in freely moving cats with implanted EEG recording both cats [12, 16] and rats. In cats, a moderate dose primarily reduced the deep SWS with delta electrodes, injection of serotonin into the fourth activity [17] ; the same was the case in rats [18] .
effect of dietary l-tryptophan. However, carbohydrate ingestion alters the brain uptake in favour The insomnia is reversed by 5-hydroxytryptophan of l-tryptophan [25] . In a study of l-tryptophan (5-HTP), serotonin's immediate precursor [16, 19] , effects in humans in the daytime, we found reduced although after a delay of 30-60 min [19] . After a sleep latency compared with placebo as well as moderate pCPA dose, presumably leaving some of increased EEG alpha activity during waking, sugthe enzyme still active, the pCPA-induced insomnia gesting a deactivation effect [26] . Plasma melatonin in rats may be reversed by l-tryptophan [18] or by is increased following L-tryptophan infusions [27] , a selective serotonin re-uptake inhibitor [20] .
and thus the effect may not solely be a result of The pCPA data imply that, without serotonin in increased serotonin. For a while, l-tryptophan was the brain, there is no sleep. However, with chronic being used as a hypnotic, until such use was halted by administration of pCPA, sleep eventually reappears, the report of several cases of eosinophilia-myalgia while brain serotonin is still very low [21] . Following syndrome, some leading to death, following intake pCPA administration, there is a "release" of the of the amino acid [28] . Most likely, however, this ponto-geniculo-occipital (PGO) activity, which norwas due to a contamination of one particular prodmally accompanies rapid eye movement (REM) sleep uct [25] . In cats, l-tryptophan increases drowsiness in cats. It was hypothesized that this activity initially [23] . In rats, the results are variable and seem to activated the animals, until habituation occurred depend on dose, route of administration and also [21] . However, close observation indicated that the time of day [29] . insomnia starts much earlier than the increase in
In sum, the serotonin precursors seem primarily PGO activity [22] .
to induce drowsiness, and the reduced sleep latency and sleep effects may be a consequence of this sedation. The hypersynchrony seen especially after
Increasing brain serotonin via precursor
5-HTP but also following l-tryptophan is consistent administration with the earlier findings on serotonin application to the brain discussed above and with some more Serotonin is formed within serotonergic neurones recent pharmacological data discussed later. from the amino acid precursor l-tryptophan, by the enzyme tryptophan hydroxylase, which is the ratelimiting factor. This enzyme is found only within The reports on the unit activity of dorsal raphe place also outside serotonergic neurones (see [23] neurones [30] [31] [32] were the introduction to a new for references). era in serotonin-sleep research. Together with the As mentioned above, the immediate precursor data on cooling of the raphe nucleus [15] , these 5-HTP reverses the insomnia induced by pCPA and data were the first to seriously question the seromakes the animals go back to sleep. Given alone, tonin-sleep hypothesis. However, the neurohowever, 5-HTP tends to induce hypersynchrony physiological data were also the result of an [19] or drowsiness, which in cats is characterized important development of techniques, making it by a 6-8 c/sec synchronous EEG activity. It is possible to collect data from unanaesthetized, sponpossible that these effects are due to serotonin taneously sleeping animals (e.g. unit recording and formation outside serotonergic neurones [23] . microdialysis data). This development was parHartmann et al. [24] found a reduction of sleep allelled by developments in pharmacological relatency following a low dose (1 mg) of l-tryptophan.
THE LAST 25 YEARS OF
search on serotonergic neurotransmission, with the With a larger load of l-tryptophan, there was no introduction of selective serotonin re-uptake infurther improvement of sleep latency, but an inhibitors and the description of a variety of subtypes crease of SWS and a reduction of REM sleep. The of serotonergic receptors and increasingly specific 1 mg dose is within the range of normal dietary agonists and antagonists to these receptors. Reintake, although competition for serotonin uptake cently, developments within molecular biology and genetics have also benefited sleep research. in the brain with other amino acids may reduce the the microdialysis data, suggest a modulating activity Dorsal raphe neuronal activity and of the raphe neurones, in phase with the state of release of serotonin throughout the the animal. Two major questions arise: is the raphe sleep-wake cycle neurone activity instrumental in defining where the The first study of unit recordings from the dorsal animal is on the sleep-wake axis and is the relation raphe nucleus area, in spontaneously sleeping cats, to the sleep-wake axis an innate function of these was published in 1976 [30] . The neurones had neurones or is it based on afferent information their highest activity in waking, and the activity was from other parts of the brain? reduced during SWS to almost complete cessation
The presence of GABAergic function in the dorsal of firing during REM sleep. These data were soon raphe neurones has long been recognized. Recently confirmed [31, 32] . It was also reported that stimuit was demonstrated that extracellular levels of lation of the dorsal raphe nucleus induced wake--aminobutyric acid (GABA) in the dorsal raphe fulness [32] . By means of a fluorescent labelling nucleus are higher in REM sleep than during waking technique it has been demonstrated that the cells and non-REM (NREM) sleep [40] . Following ionresponsible for the dorsal raphe neurone firing tophoretic application of a GABA A antagonist into pattern are serotonergic [33] . The state dependence the dorsal raphe nucleus, the firing activity of the has mostly been investigated in the dorsal raphe cells was not suppressed during SWS, suggesting nucleus. However, the pattern is generally similar GABAergic modulation as the background for this in the other raphe nuclei, with some exceptions, relationship [41] .
There is also evidence for cholinergic, glutaone being that some of the caudally projecting nuclei matergic, noradrenergic, dopaminergic and histaare less related to behavioural state [33] . minergic input to the the dorsal raphe nucleus Recently, the firing pattern of putative sero- [33] . Recently, hypocretin/orexin projections to the tonergic neurones has also been studied in rats raphe nuclei have been described (see [42] ). The [34] . The neurones exhibit progressive decrease in implications for serotonergic sleep-wake effects of discharge rate from waking through SWS to REM these findings are discussed below. sleep. The discharge is reduced after systemic administration of a selective 5-HT 1A agonist, indicating that it stems from serotonergic neurones.
Selective serotonin re-uptake inhibitor
The findings on extracellular content of serotonin effects on sleep in different brain areas have recently been reviewed [3] . There seems to be a general tendency that
The antidepressive selective serotonin re-uptake serotonin measured in the extracellular fluid, which inhibitors (SSRIs) seem to be ideal drugs to inpresumably mirrors the actual release in the area vestigate serotonergic effects, in that they will, where it is measured, is highest during waking, is by inhibiting the re-uptake of serotonin from the reduced during SWS and more reduced during REM synaptic cleft, only increase serotonin released at sleep. This is the case in the dorsal raphe nucleus serotonergic terminals, and only when serotonin is in both cats [35] and rats [36] , in the brain stem released after physiological activity in serotonergic pedunculopontine tegmental (PPT) nucleus in cats neurones. [37] and in hippocampus in rats [38] . The pattern Depressive patients generally complain about disis largely consistent with data on the firing activity turbed sleep, such as sleep onset insomnia, fragof the dorsal raphe nucleus in cats [30] [31] [32] and rats mented sleep with frequent awakenings and early [34] , with the exception that the values measured morning awakenings. When recorded polyduring REM sleep are comparatively less reduced graphically their sleep shows characteristic changes than the firing decrement in this stage. This may be which may suggest defective serotonergic neuroan effect of the methodology [37] or it may indicate transmission: reduced REM sleep latency, increased release without firing. Dendritic release of serotonin phasic REM sleep activity and reduced deep slow in the dorsal raphe nucleus during sleep has been wave (delta) sleep. The most consistent effect of suggested as being important for the reduction of the SSRIs, in all species, is a reduction of REM dorsal raphe neuronal activity in SWS and REM sleep, supporting the hypothesis of a serotonergic sleep, via somatodendritic autoreceptors [39] .
inhibition of REM sleep discussed below. It has been suggested that the antidepressant effect is tied to The data on raphe neurone activity, as well as this effect. However, recently, antidepressant drugs
Is the receptor subtype important?
which do not suppress REM sleep have been deWith the description of multiple serotonergic reveloped, invalidating the REM sleep hypothesis [43] .
ceptors [50] , the question arouse whether it was Other sleep effects of the SSRIs vary, with the possible to assign the divergent effects of serotonin drug and with the species in which they are inon sleep to different receptors. The development vestigated. In humans, the REM sleep suppressant of multiple pharmaceutical agents which may stimueffect is prominent. There is usually no sedative late or block the various receptors has been central effect, but the antidepressant effect of the SSRIs in this research. Most of the work on this aspect tends to improve insomnia complaints in depression of the serotonin-sleep-waking problem so far has [44] , although insomnia is a possible side-effect with been done on the 5-HT 1A and 5-HT 2 receptor and some SSRIs. In cats and rats, there is a tendency to has been reviewed in detail [2] . biphasic effects following acute administration of
The 5-HT 2 receptor antagonist ritanserin proSSRIs. In cats, waking is increased initially, then after motes sleep in both humans [51] and rats [52] , a delay of around 2 h there is an SWS increase, suggesting that this receptor was promoting waking particularly SWS-2 with delta activity [45, 46] . This activity, although in cats the antagonist reduces effect is potentiated with 5-HTP pre-treatment [47] .
sleep [53] . However, ritanserin did not block the The findings opened for the idea that serotonergic SSRI waking effects in rats, just adding to the SWS stimulation yields complex effects on the sleepeffect [54] , suggesting different mechanisms. Also, waking axis, both sleep-incompatible and sleeppower spectral data indicated that the sleep folpromoting effects [20] . The increase in waking is lowing ritanserin was different from normal sleep accompanied by behavioural and motor phenomena [55] . A mechanism for an arousing effect of 5-HT 2 and may be secondary to those [46] . In rats, inreceptors may be found in the thalamic reticular creased waking followed by increased SWS or SWSnucleus and the sleep spindle generating network 2 has been reported from several but not all studies of relay cells, cortical cells and reticular nucleus cells following different SSRIs (see [1] for references).
[56]. The 5-HT 2 receptors have been postulated to The biphasic effect is potentiated by an adenosine modulate the activity in the thalamus in the direction A 1 antagonist, suggesting modulation of serotonin of single spike activity, i.e. waking [57] . Thus, serorelease by adenosine [48] .
tonin acting on 5-HT 2 receptors in the thalamus There are regional differences in effects of difmay facilitate single spike activity and waking, but ferent SSRIs. The synchronizing effect is less prothis does not seem to be the full answer to why nounced in both cats and rats following an SSRI serotonergic stimulation leads to waking. with low potency in the dorsal raphe and the
The 5-HT 1A receptors are located postdescending raphe projection [20, 46] . Thus the synaptically on many neurones, as well as localization of the serotonergic effect may be imsomatodendritically on dorsal raphe neurones. portant for the type of effect on sleep and waking.
Stimulation of the somatodendritic autoreceptors A synchronizing effect via serotonergic modulation presumably leads to reduction of the neuroneal of ascending sensory information from the spinal activity. Extracellular serotonin decreased following cord has been suggested [49] . microdialysis application of the 5-HT 1A agonist 8-Practice Points OH-DPAT into the dorsal raphe in cats [58] , supporting the concept of release control by the so-1. Administration of the serotonin precursor matodendritic 5-HT 1A autoreceptors in the raphe amino acid l-tryptophan reduces sleep latency.
neurones. Perfused into the dorsal raphe nucleus, A protein-rich meal followed by carbohydrate 8-OH-DPAT increase REM sleep but has no effect intake 2 h later may have the same effect.
on other sleep stages [58, 59] . to increase waking. Administration of the agonist 3. SSRIs improve sleep complaints in depressive 8-OH-DPAT increases waking and reduces REM patients as a part of the antidepressive effect.
sleep; however, within SWS, there is a delayed SSRIs are not effective as hypnotics, and may increase of highly synchronized sleep (SWS-2) [59] . have insomnia as a side-effect.
The 5-HT 1A agonist ipsapiron increases slow wave activity in both humans [60] and rats [61] . In vitro forebrain-pre-optic area in cats. Also, sleep was stimulation of 5-HT 1A receptors on basal forebrain reduced after electrolytic preoptic lesions [66] . cholinergic neurones increases rhythmic burst acSleep active cells are found in the ventrolateral pretivity mediated by low threshold calcium spikes optic (VLPO) area in cats [67] , and a population of [62] . Thus, possibly, 5-HT 1A receptor stimulation in cells which showed c-fos activation after sleep was the forebrain may facilitate if not SWS at least described in rats [68] . Lesions of the VLPO cluster synchronization within SWS. In the spinal cord, cause reduction in NREM sleep and delta activity, local infusion of 8-OH-DPAT reduces waking and while lesions in the region containing scattered increases SWS, but does not increase SWS-2 in VLPO neurones medial or dorsal to the cluster are particular [49] . This suggests a deactivating effect of more associated with loss of REM sleep [69] . spinal serotonergic transmission. This is consistent
The GABAergic neurones identified in this area with the finding of differential effects on SWS-2 of have been implicated in the sleep-promoting effects different SSRIs discussed above [46] .
[63]. Many of the cells also contain galanin [70] . Thus there are some indications that 5-HT 1A Several recent studies suggest a reciprocal interreceptors may facilitate sleep or sleep charaction between this area and serotonergic raphe acteristics at least in some central nervous system neurones. In vitro data indicate that some of the areas. [13] has suggested that serotonin released in the whether the effect stems from post-synaptic repreoptic region during waking may participate in a ceptors or whether the effect is a result of altered homeostatic sleep factor process. The clock-like serotonin release at the terminals secondary to action of dorsal raphe neurones may be marking modulation of the autoreceptors. duration and intensity of waking, then herald a cascade of genomic events which will trigger sleep onset. Such a chain of events may involve the The preoptic/basal forebrain area, sleep modulation by serotonin of preoptic-VLPO area and serotonin neurotransmitter projections as described above or, possibly, the serotonergic modulation of the This area has been in focus as a possible site for sleep-promoting hormones vasoactive intestinal sleep-wake regulation for many decades. A group peptide (VIP) and prolactin described below. The of cholinergic cells which project monosynaptically sleep-active cells are also thermosensitive, and preto the entire limbic telencephalon and neocortex, optic warming slows down the activity of neurones modulating arousal and attention, is located here in hypothalamus and (presumably serotonergic) cells (reviewed in [63] ). However, the area has a longer in dorsal raphe with high activity during waking [34] . history of research on sleep-promoting functions.
The cholinergic basal forebrain cells receive afOn the basis of von Economo's findings in an ferent input from both the dorsal and the median insomniac subgroup of patients suffering from enraphe nuclei, with both excitatory and inhibitory cephalitis lethargica, Nauta [64] did transections of effects [74] . Although only a minority of these the anterior hypothalamus at the level of the optic connections are serotonergic, a serotonergic modchiasm in rats. He found that the rats displayed ulation of these neurones, and thereby modulation continuous motor activity until they died after a of cortical activation, is possible. Recently it was few days. Many years later this was followed up by demonstrated that sleep deprivation in cats inSterman and Clemente [65] who demonstrated that sleep could be induced by stimulation of the basal creases basal forebrain adenosine as measured by microdialysis [75] . A prominent effect of adenosine mediated via prolactin. There also prolactin-conin the brain is its ability to inhibit the release taining neurones in the hypothalamus and preoptic of neurotransmitters, including serotonin. These area. Hypothalamic prolactin is thought to pareffects are probably mediated by pre-synaptic A 1 ticipate in the modulation of neurotransmission receptors in most systems and may be due to involved in REM sleep generation [83] . Apparently inhibition of calcium entry into nerve terminals the distribution of neurones described as prolactin (reviewed in [76]). Thus, one possible mechanism immunoreactive is similar to the distribution of the for the sleep effects of adenosine is via adenosinergic hypocretin/orexin neurones, and it has recently modulation of serotonin release. It has been dembeen demonstrated that hypocretin/orexin and proonstrated that adenosine perfused into the dorsal lactin coexist in the same neurones [84] . Thus there hippocampus of rats decrease extracellular 5-HT are possibilities of an interplay between hypocretin/ levels [77] .
orexin, prolactin and serotonin in sleep modulation and in narcolepsy. The mechanisms of such interactions remain to be elucidated.
Dorsolateral hypothalamus, hypocretin/ orexin, serotonin and sleep Circadian rhythm, the suprachiasmatic
Recently, a new peptide, hypocretin or orexin has nucleus, serotonin and sleep been described in neurones of the dorsal and lateral hypothalamus (see overview by Mignot [42]). Two The suprachiasmatic nucleus (SCN), which is central versions of the peptide, hypocretin 1 and 2 or in the regulation of circadian rhythm, has one of orexin A and B, and corresponding receptors have the densest serotonergic terminal plexes in the been described. It appears that narcoleptic dogs brain. Also, the intergeniculate leaflet which projects have a mutation in the hypocretin 2/orexin B gene.
to the SCN receives serotonergic input from the Some but not all narcoleptic patients are deficient of dorsal raphe nucleus, while SCN receives input hypocretin in the spinal fluid. Also, orexin knockout from the median raphe nucleus [4] . However, it is mice have episodes of behavioural arrests similar not clear how serotonin is involved in the modto human narcolepsy [78] . The hypocretin/orexin ulation of the circadian rhythm. It has been suggested neurones have wide projections to multiple neurthat serotonin modulates the sensitivity of the cironal systems [79] , in particular to many areas of cadian system to light [4] . Another hypothesis is the hypothalamus and amygdala. They project to that serotonin mediates phase-shifting effects of areas which may be involved in sleep and arousal:
behavioural stimuli on circadian rhythms [85] . Serothe tuberomammillary nucleus, the locus coeruleus, tonin can advance the pacemaker when applied the raphe nulei, the PPT nucleus, the laterodorsal during the subjective day and delay the pacemaker tegmental (LDT) nucleus and the nucleus tractus when applied during the subjective night [86] . In solitarius. The effect is excitatory, and it has been vitro data implicate stimulation of 5-HT 7 receptors speculated that the hypocretin/orexin projections on pacemaker cells in the phase advance effect may drive the modulatory effects on sleep and of serotonin. A number of neuromodulators may waking attributed to these areas [42] . An arousing influence the serotonergic phase shifts [86] . There effect of hypocretin 1/orexin A together with are projections, both exitatory and inhibitory, from activation of locus coeruleus firing has been the SCN to the preoptic area which may convey demonstrated by intracerebroventricular (i.c.v.) apinformation on circadian phase to this sleep-proplication in rats [80] , and local administration into moting area [87] . the locus coeruelus increases waking and suppresses SWS and REM sleep [81] .
I.c.v. administration of hypocretin 1/orexin also Thalamocortical projections, sleep suppress plasma prolactin [80] . Prolactin is secreted spindles and serotonin during sleep. Data indicate that serotonin, acting The 7-14 c/sec sleep spindles which identify the directly at the posterior pituitary, stimulates the onset of sleep in the EEG are the result of a secretion of prolactin and VIP, probably by releasing thalamocortical oscillatory process generating an unidentified mediator from melanotropes [82] . The hypnogenic effect of VIP (see [13] ) is probably rhythmic burst activity by low threshold Ca 2+ spikes.
GABAergic neurones of the reticular nucleus, thal-

Serotonin and REM sleep
amocortical relay cells and cortical pyramidal cells One characteristic aspect of dorsal raphe neurone participate in the spindle generation [56] . This osactivity is the reduction of firing to almost nothing cillatory activity may be modulated by neuroduring REM sleep. This phenomenon is not unique transmitters, including serotonin. There is a dense for the serotonergic neurones; it also applies to serotonergic innervation of the reticular nucleus, the neuroneal activity of the noradrenergic locus possibly arising from the dorsal raphe nucleus or coeruleus neurones. A model for the alternation the nucleus raphe pontis. The receptors involved between SWS and REM sleep postulates either the in this modulation are probably 5-HT 2 receptors locus coeruleus or the raphe nucleus as the REM (reviewed in [88] ). Serotonin has a potent excitatory sleep inhibitory area [90, 91] . action on the GABAergic reticular nucleus neurones Pharmacological studies indicate that increased in vitro, associated with the occurrence of singlesynaptic serotonin reduces REM sleep. Increasing spike activity. However, within a certain range of brain serotonergic activity by precursor loading the membrane potential, i.e. with moderate dewith 5-HTP and l-tryptophan [19, 23] , as well as polarization, there is an increased probability of with SSRI administration [20, 46] , reduces REM rhythmic oscillations. This is consistent with a model sleep. for control of reticular thalamic oscillations [89] .
REM sleep is generated in the pontine region of In this model it is proposed that the oscillating the brainstem. A thorough overview of the research properties of the reticular nucleus depends on the leading to this conclusion is given by Siegel [92] . level of the membrane potential, which may be Different, but adjacent, structures in this region modulated by serotonin and noradrenalin by the have been implicated in REM sleep generation. The blocking of a potassium current ("leak K . The serotonergic modulation of REM sleep is is resting hyperpolarization and no oscillations, while postulated to be due to stimulation of 5-HT 1A strong serotonergic input lead to depolarization receptors in the LDT and PPT nuclei. There is and a switch to single-spike activity as in waking.
evidence that LDT and PPT nuclei receive serThis excitation of the reticular nucleus neurones otonergic fibres [93] , and serotonin is released in probably occurs through activation of 5-HT 2 the PPT nucleus in a state-related manner, highest receptors. In behaving cats, there is a decrease during waking and lowest during REM sleep [37] . of dorsal raphe unit activity before and during, Some of the neurones in these nuclei show prefbut not after, the occurence of a sleep spindle erential activity during REM sleep ("REM-on cells") [31] .
[91]. Lesions in this area decrease REM sleep, while During later stages of sleep, the spindle oselectrical stimulation of the LDT nucleus increase cillations are progressively reduced and replaced REM sleep [94] . When these neurones are perfused by thalamocortical oscillations with slower frevia microdialysis with the 5-HT 1A agonist 8-OHquencies, delta waves [1-4 Hz] and slow os-DPAT, the discharge is almost completely supcillations. Hyperpolarization of the cells is essential pressed [95] , supposedly as a result of inhibition for the generation of delta waves, which, in of the REM-on cells [91] . Consistent with this, contrast to the sleep spindle generation, may take microinjection of serotonin into the LDT nucleus place in single cells (basal forebrain cells [62] , suppresses REM sleep [96] . Also, infusion of a thalamic sensory relay cells and cortical cells 5-HT 1A agonist in the dorsal raphe nucleus via [56] ). The delta wave activity in cortical cells is microdialysis increases REM sleep in both cats [58] synchronized via local mechanisms or via thalamic and rats [59] , presumbaly via stimulation of dorsal interconnections [56] . Serotonin can modulate the raphe autoreceptors, reduced serotonin release and excitability of cortical cells in a number of different reduced serotonergic inhibition of the REM sleep manners, including inhibition, excitation and voltgenerating neurones. Systemic administration of a age-dependent facilitation. Also, a mix of the 5-HT 1A antagonist reduces REM sleep, presumably different actions of serotonin in different types via antagonism of the autoreceptors and increased of cells may result in even more complex modulation [88] .
serotonin release and REM sleep inhibition [97] .
Another area which has been implicated in the whether the raphe neurone activity, and target organ serotonin release, is instrumental in defining generation of REM sleep is an area adjacent to the where the animal is on the sleep-wake axis. If so, locus coeruleus, peri-locus coeruleus alpha in the is it the amount of activity of raphe neurones, and medio-dorsal pontine tegmentum (see [92] ). Neurserotonin release, which determines the state, or ones in this area display an increase in discharge has the frequency, or possibly pattern, of raphe rate just prior to and during REM sleep [98] , and neurone firing any information value in itself? An lesions suppress REM sleep [99] . Application by example of a possible frequency dependence is the microdialysis of noradrenaline and adrenaline, but "window" for sleep spindle activity in the thalamus, not serotonin, to this area suppresses REM sleep;
where a moderate serotonergic input may slightly in the rostral area noradrenaline and adrenaline depolarize the reticular nucleus and generate osinduce REM sleep without atonia [100] . There are also indications of differential effects release within the dorsal raphe [101, 102] . Adwith regard to sleep and waking dependent on the ministration of NO synthesis inhibitors into the type of receptors receiving the serotonergic input mesopontine reticular formation of cats also deand where they are located. In the thalamus, 5-creases REM sleep, interpreted as an effect via HT 2 receptors are probably responsible for the modulation of acetylcholine release [103] . Some excitation of the reticular nucleus leading to singlestudies also find an effect on SWS of NO modulation spike activity and waking. This could be an important in the PPT nucleus. mechanism for the arousing effects of serotonin. It could also be a mechanism by which serotonin modulates the oscillatory activity of the reticular CONCLUSION nucleus and thereby the state of the individual. Serotonin may also modulate cortical activation, via The central characteristic of most of the sermodulation of the cholinergic basal forebrain cells, otonergic raphe neurones is their activity in relation or modulation of cortical cells. More directly, 5-to the sleep-wake cycle. According to Jacobs and HT 1A receptor stimulation seems to facilitate deep Azmitia [33] serotonin acts to modulate the function SWS or at least slow wave activity within sleep. of target organs with respect to the sleep-wake
The mechanism for this effect is not clear. Several axis. A common way of interpreting the raphe data sets point towards the descending raphe nuclei activity data is, however, much more simple: the for mediating such effects; also, the basal forebrain dorsal raphe and serotonergic neurotransmission is has been implicated via (in vitro) data on oscillatory seen as an arousal system [42, 70] , being turned activity via 5-HT 1A receptors. Jouvet [13] has sugmore or less off during sleep. Alternatively, as gested that release of serotonin during waking may suggested by Jouvet [13], the dorsal raphe activity initiate a cascade of genomic events in neurones initiates a process which eventually results in sleep.
in the preoptic area, thus linking serotonin to a homeostatic regulation of SWS. One may also raise the more subtle question of 
